Clinical Trials Articles

Science & Innovation

How AI Is Already Reshaping Cancer Care

When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on...

March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels.This March, we received another accolade (Ethisphere recognized Pfizer as one of the World’s Most Ethical Companies for the fifth year in a row), shared new episodes of “Science Will Win” and “What’s In My Lab”, and provided a behind-the-scenes look at our commitment to fighting cancer.We also published our 2025 Annual Review, with opening remarks from CEO Albert Bourla, while...

February Social Media Round-Up—World Cancer Day, Science Will Win, and More

The groundhog may have predicted six more weeks of winter, but here at Pfizer we’re predicting blue skies ahead as we wrap up another great month.We kicked off February with the launch of season six of “Science Will Win”—Pfizer’s award-winning podcast, announced the launch of The Empowering Women in IBD Leadership program, shared positive results in an ongoing study in patients with metastatic colorectal cancer, and much more.CEO Albert Bourla celebrated World Cancer Day by highlighting the...

Powered by Purpose: Celebrating Clinical Trials Day 2025

Pfizer has been in the business of breakthroughs for nearly two centuries, and while our success represents the shared work of thousands of our dedicated employees, none of the advancements for which we are known were made possible through our efforts alone. The modern prescription medicines and vaccines we have today were studied in hundreds, and often thousands, of people in clinical trials.A clinical trial is a research study that seeks to understand how potential medicines, vaccines, and...

Science & Innovation

The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model

During the early months of 2020, decentralized modalities to conduct clinical trials went mainstream as a solution to a short-term problem: how to continue clinical trials amid pandemic closures. At Pfizer, however, remote trials and the use of digital tools to conduct clinical trials were implemented long before the pandemic. Increased adoption of modalities like telehealth visits became catalysts for how — and where — clinical research could be done.What's more, surveys show that participants...

July Social Media Round-Up—Summer Interns, 175 Days of Good, and More

Pfizer jumped into the summer holidays with another eventful month. This July, we recognized the accomplishments of our leadership team, gave back to our communities by leading volunteer events for “175 Days of Good”, and shared positive results from various clinical trials.See what our leadership has been up to then catch up on our corporate social accounts where we shine a spotlight on Pfizer partners, colleagues, and communities.Stay tuned for more updates!Executive LeadershipCEO Albert...

Purpose & Ideals

Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design

Every day, across the United States and around the world, scientists are developing potential new medicines and vaccines that could change lives. But to get medicines and vaccines to the patients who need them most, they must first undergo a clinical trial, which is a research study that seeks to understand how potential medicines and other medical treatments work.These studies depend on the generosity of participants, who volunteer to be a part of the trial. Depending on the type of trial...

May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care

The month of May not only brought flowers, but also noteworthy celebrations at Pfizer. We recognized the contributions of the Pfizer community and beyond, from the trailblazers that support clinical research to Pfizer teammates whose impact led to our inclusion on TIME’s top 100 companies list, including our CEO, who was named by TIME as one of the most influential people in the healthcare industry.Take a moment to catch up on social posts from our corporate channels – featuring a TikTok tour of...

Programs & Initiatives

The Importance of Returning Clinical Trial Data to Participants

Clinical trial participants are at the heart of medical research, and it’s with their help that Pfizer is able to bring life-changing treatments to patients.But, until recently, clinical trial sponsors like Pfizer have not been equipped to provide participants with their own personal clinical trial data when a trial ends. Pfizer’s team of clinical trial experts have worked for many years to change that by launching the Clinical Trial Participant Data Return Initiative.This first-of-its-kind...

September Social Media Round-Up—DEI, CMO, and Rocky Mount Resumes

This September, Albert Bourla, Pfizer’s CEO, attended Black Corporate Directors Conference to discuss minority representation across all sectors, and our social roundup starts with his thoughts on their mission. Our Chief Marketing Officer discusses his first year as Pfizer’s first CMO and where we go from here. It’s an illuminating read from an innovative thinker. In other news, we made a TIME Magazine list, announced a new plan to make sure clinical trials participants have access to their...

July Social Media Round-Up—Rocky Mount Update, Rady Johnson Honored, and Vaccine Progress

On July 20, a tornado touched down in North Carolina, injuring 16 people and damaging a Pfizer plant in Rocky Mount, one of the largest manufacturers of sterile injectable drugs in the world. This month’s social media round-up kicks off with a statement from CEO Albert Bourla about the tornado and its impact on Pfizer. In other news, we also announced a new partnership in drug discovery, helped our summer workers settle in, and saw positive results in vaccine development. Catch up below. FRO...

Listen Now—Science Will Win Season 2 Takes on Breast Cancer

Science Will Win, one of Pfizer’s premiere podcasts, is back! This season we’ll explore the advancements and the challenges of cancer treatments, particularly in the breast cancer space. In this special two-part series, we’re looking at how the increasingly innovative medications used to treat cancer come to be.Part one: Breast Cancer: The Science, The Challenges, The Solutions Get a better sense of what breast cancer is and dive into some of the early-stage research underway to find new...